近期论文

查看导师新发文章 （温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Martin, K., D. Johnstone, R. M. Graham, D. van Helden, K. Kerr, S. Hollins, D. Laver, J. Olynyk, D. Trinder, and L. Milward. 2016.“Alterations in cardiac iron status, electrophysiological responses and transcript levels in mouse models of dietary and genetic iron loading.”American Journal of Hematology 91 (3): E160-E160. Heidari, M., D. Johnstone, B. Bassett, R. Horn, K. Martin, D. Huff, J. Montgomery, C. Bettencourt, A. Chua, R. M. Graham et al. 2016.“Brain iron localizes to myelin and affects expression of genes related to myelin and neurodegeneration with brain iron accumulation disorders in mice with disruption of HFE and TFR2.”American Journal of Hematology 91 (3): 1-9. Johnstone, D., C. Riveros, M. Heidari, R. M. Graham, D. Trinder, R. Berretta, J. Olynyk, R. Scott, P. Moscato, and E. A. Milward. 2013.“Evaluation of Differential Normalization and Analysis Procedures for Illumina Gene Expression Microarray Data Involving Small Changes.”Microarrays 2: 131-152. Acikyol, B., R. M. Graham, D. Trinder, M. J. House, J. Olynyk, R. Scott, E. A. Milward, and D. M. Johnstone. 2013.“Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation.”Neuroscience 235: 119-128. Graham, R. M., A. C. Chua, and D. Trinder. 2012. “Plasma iron and iron delivery to the tissues.” In Iron Physiology and Pathophysiology in Humans, ed. Gregory J Anderson, Gordon D McLaren, 117-140. Vienna: Humana Press. Milward, E. A., B. Acikyol, B. Bassett, E. Williams, R. M. Graham, R. Delima, D. Trinder, J. Olynyk, and D. Johnstone. 2012. “Brain Changes in Iron Loading Disorders.” In Metal Ions in Neurological Systems, ed. Wolfgang Linert, Henryk Kozlowski, 17-29. Vienna: Springer-Verlag. Johnstone, D., R. M. Graham, D. Trinder, R. Delima, C. Riveros, J. Olynyk, R. J. Scott, P. Moscato, and E. A. Milward. 2012.“Brain transcriptome perturbations in the Hfe -/- mouse model of genetic iron loading.”Brain Research 1448: 144-152. Delima, R., A. Chua, J. E. Tirnitz-Parker, E. Gan, K. D. Croft, R. M. Graham, J. Olynyk, and D. Trinder. 2012.“Disruption of hemochromatosis protein and transferrin receptor 2 causes iron-induced liver injury in mice.”Hepatology 56 (2): 585-593. Johnstone, D., R. M. Graham, D. Trinder, C. Riveros, J. Olynyk, R. Scott, P. Moscato, and E. A. Milward. 2012.“Changes in Brain Transcripts Related to Alzheimer’s Disease in a Model of HFE Hemochromatosis are not Consistent with Increased Alzheimer’s Disease Risk.”Journal of Alzheimer's Disease 30: 791-803. Petty, W., W. Voelzke, J. Urbanic, V. Varela, L. Waller, C. Swift, R. M. Graham, V. Memoli, and K. Dragnev. 2011.“High cyclin D3 expression confers erlotinib resistance in aerodigestive tract cancer.”Lung Cancer 74 (3): 384-391. Herbison, C. E., K. Thorstensen, A. C. Chua, R. M. Graham, P. J. Leedman, J. Olynyk, and D. Trinder. 2009.“The role of transferrin receptor 1 and 2 in transferrin-bound iron uptake in human hepatoma cells.”American Journal of Physiology - Cell Physiology 297 (6): C1567-C1575. Schroeder, S., A. Lawrence, R. Biedendieck, R. Rose, E. Deery, R. M. Graham, K. McLean, A. Munro, S. Rigby, and M. Warren. 2009.“Demonstration that CobG, the monooxygenase associated with the ring contraction process of the aerobic cobalamin (vitamin B12) biosynthetic pathway, contains an Fe-S center and a mononuclear non-heme iron center.”Journal of Biological Chemistry 284 (8): 4796-4805. Sørensen, A., C. Reis, M. Tarp, U. Mandel, K. Ramachandran, V. Sankaranarayanan, T. Schwientek, R. M. Graham, J. Taylor-Papadimitriou, M. Hollingsworth et al. 2006.“Chemoenzymatically synthesized multimeric Tn/STn MUC1 glycopeptides elicit cancer-specific anti-MUC1 antibody responses and override tolerance.”Glycobiology 16 (2): 96-107. Vévodová, J., R. M. Graham, E. Raux, M. Warren, and K. Wilson. 2005.“Crystallization and preliminary structure analysis of CobE, an essential protein of cobalamin (vitamin B12) biosynthesis.”Acta Crystallographica Section F: Structural Biology and Crystallization Communications 61 (4): 442-444. Graham, R. M., E. Morgan, and E. Baker. 1998.“Ferric citrate uptake by cultured rat hepatocytes is inhibited in the presence of transferrin.”FEBS Journal 253 (1): 139-145. Graham, R. M., C. Stephens, W. Silvester, L. Leong, M. Sturm, and R. Taylor. 1994.“Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis.”Critical Care Medicine 22 (2): 204-212. Stephens, C., R. M. Graham, M. Sturm, M. Richardson, and R. Taylor. 1993.“Variation in plasma platelet-activating factor degradation and serum lipids after acute myocardial infarction.”Coronary Artery Disease 4 (2): 187-193. Davis, T., M. Sturm, Y. Zhang, J. Spencer, R. M. Graham, G. Li, and R. Taylor. 1993.“Platelet-activating factor and lipid metabolism in acute malaria.”Journal of Infection 26 (3): 279-285. Stephens, C., R. M. Graham, O. Yadava, L. Leong, M. Sturm, and R. Taylor. 1992.“Plasma platelet activating factor degradation and serum lipids after coronary bypass surgery.”Cardiovascular Research 26 (1): 25-31.